Back Pall Enters Laboratory Water Market With New Cascada Lab Water System East Hills, NY (February 28, 2005) - - The need for purified water, so as not to impact test results, is an essential and growing requirement of research and diagnostic laboratories, especially as testing equipment becomes more sensitive and more stringent regulations are promulgated globally. To meet these demanding life science and analytical testing requirements, Pall Corporation (NYSE: PLL), the global leader in filtration, separations and purification, announced that it is bringing its water purification expertise to the laboratory market with the introduction of the Pall Cascada™ Lab Water Systems. The Cascada point-of-use system provides optimum water quality to support diverse laboratory needs from the most critical, sensitive applications through general-purpose use. “As the lab market becomes increasingly complex and demanding, customers need trustworthy providers that are deeply entrenched in water purification,” says Ken L. Harris, President Pall Life Sciences New Technology. “Pall’s entry into this marketplace combines more than a half century experience in the development of the most advanced water purification technologies used by a host of industries worldwide with our in-depth, extensive knowledge and understanding of the diverse application needs of the laboratory markets we serve.” The Cascada System enables laboratories to achieve the highest purity water through a series of separation and purification steps in a single box on demand. Four polishing systems, with customized configurations to meet a wide range of sensitive application requirements for high quality ultrapure water, are available. They are: The Cascada BIO-water, a polishing system for demanding life sciences applications such as cell culture, in vitro fertilization, microfluidic and array systems; The Cascada AN-water, a polisher for demanding analytical applications such as ultra-trace environmental analysis; The Cascada IX-water, a polishing system for less demanding lab water applications; and  The Cascada LS-water polisher for general-purpose lab analysis, including less sensitive life science applications. A pretreatment system, the Cascada RO-water system is also available to protect and extend the life of the polishers, which is particularly important in cases where there is poor feedwater quality. The Cascada Systems offer a multitude of benefits including multi-stage monitoring, data tagging, intelligent dispensing and “real-time” total organic carbon (TOC) monitoring. The systems can be comprehensively and completely sanitized. Each of the products has full FDA validation pages and traceable cartridges back to the source.  Expanding Market with Unmet Needs “The lab water market continues to expand and rapid technological growth in regions of the world, such as Asia and Latin America, still have many unmet needs.  We are confident we will be one of the leading providers of point-of-use laboratory water systems in the near future,” says Mr. Harris. The global laboratory water systems and consumables market is estimated at  $250 million dollars, growing at a rate of about 8 percent annually. “Pall selected the best available technology for our new system to monitor and protect the quality of the output water at the least cost of ownership for academic, clinical, biopharmaceutical and pharmaceutical research laboratories,” Mr. Harris adds. “The new Cascada system is merely the tip of the iceberg for Pall in this marketplace.“ The Company plans to extend its dominant position in water purification by utilizing its proprietary technologies to continue to refine systems and lead in the growing, changing and ever more demanding laboratory water market. About Pall Corporation Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductors, water purification, aerospace and broad industrial markets. Total revenues are $1.8 billion. The Company headquarters are in East Hills, New York with extensive operations throughout the world. Visit Pall at www.pall.com. Forward-Looking Statement This release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current Company expectations and are subject to risks and uncertainties which could cause actual results to differ materially.  Such risks and uncertainties include, but are not limited to: fluctuations in foreign currency exchange rates; regulatory approval and market acceptance of new technologies; changes in product mix and product pricing and in interest rates and cost of raw materials; the Company’s success in enforcing its patents and protecting its proprietary products and manufacturing techniques and its ability to achieve the savings anticipated from its cost reduction initiatives; global and regional economic conditions and legislative, regulatory and political developments; and domestic and international competition in the Company’s global markets.  Additional information regarding these and other factors is available on the Web at www.pall.com and is included in the Company’s reports filed with the U.S. Securities and Exchange Commission.  Copies of such reports can be obtained, without charge, at www.sec.gov. Management uses certain non-GAAP measurements to assess Pall’s current and future financial performance.  The non-GAAP measurements do not replace the presentation of Pall’s GAAP financial results.  These measurements provide supplemental information to assist management in analyzing Pall’s financial position and results of operations.  Pall has chosen to provide this information to facilitate meaningful comparisons of past, present and future operating results and as a means to emphasize the results of ongoing operations. ### Contact Patricia Iannucci V.P. Investor Relations & Communications Telephone: 516-801-9848 Fax: 516-484-3649 Email: media_relations@pall.com Back